Elite Pharmaceuticals, Inc. Retained Earnings
Elite Pharmaceuticals, Inc. (ELTP) had Retained Earnings of -$69.92 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$69.92M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$75.83M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$94.29M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$112.89M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$69.92M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$75.83M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | -$94.29M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | -$112.89M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$126.59M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$120.70M 10-K · filed 2026-06-29 | |
| 2024-12-31 | -$137.70M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | -$126.81M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$115.77M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$116.39M 10-K · filed 2025-06-30 | |
| 2023-12-31 | -$119.72M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | -$120.42M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$135.36M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$136.50M 10-K · filed 2024-07-01 | |
| 2022-12-31 | -$135.27M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | -$138.24M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$139.75M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$140.06M 10-K · filed 2023-06-29 | |
| 2021-12-31 | -$142.49M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | -$144.77M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$146.57M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | -$148.96M 10-K · filed 2022-06-29 | |
| 2020-12-31 | -$148.48M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | -$150.49M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | -$152.97M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | -$154.05M 10-K · filed 2021-06-14 | |
| 2019-12-31 | -$154.98M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | -$153.12M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$151.53M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$151.81M 10-K · filed 2020-06-29 | |
| 2018-12-31 | -$149.14M 10-Q · filed 2019-02-11 | |
| 2018-09-30 | -$146.80M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$144.21M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$142.53M 10-K · filed 2019-06-21 | |
| 2017-12-31 | -$139.70M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | -$139.21M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$141.02M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | -$138.85M 10-K · filed 2018-06-14 | |
| 2016-12-31 | -$135.66M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | -$137.33M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$141.57M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$142.66M 10-K · filed 2017-06-14 | |
| 2015-12-31 | -$151.16M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | -$138.93M 10-Q · filed 2015-12-30 | -$136.94M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$137.25M 10-Q · filed 2015-12-30 | -$180.00M 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$141.98M 10-K · filed 2016-06-15 | -$196.08M 10-K · filed 2015-06-15 |
| 2014-12-31 | -$187.01M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | -$208.03M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$229.41M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$225.01M 10-K · filed 2015-06-15 | |
| 2013-12-31 | -$138.21M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | -$137.15M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$127.51M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$128.43M 10-K · filed 2014-06-30 | |
| 2012-12-31 | -$130.03M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | -$139.39M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$140.44M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$129.92M 10-K · filed 2013-06-21 | |
| 2011-12-31 | -$122.91M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | -$131.68M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$145.59M 10-Q/A · filed 2011-08-19 | |
| 2011-03-31 | -$114.86M 10-K · filed 2012-06-29 |